month, Jesse Berlin and Susan Ellenberg comment on the concerns, controversy
and confounding issues surrounding the exclusion of women from clinical trials.
Traditionally, theoretical fears about gender differences in
treatment effects and legitimate concerns of exposing fetuses to
investigational drugs have surrounded the idea of involving women in clinical
trials. Berlin and Ellenberg discuss how gender inequity in clinical research
has been challenged, and highlight the broader issue of individual differences
in biological factors, and genetic factors in particular, that may ultimately
lead to a future of personalised medicine for everybody.
We look forward to hearing from our readers and authors
about their thoughts on this polarising subject. For this and more why not sign up for article alerts from BMC Medicine?
Assistant Editor, BMC Medicine